Effects of Ramipril and vitamin E on atherosclerosis: The Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and vitamin E (SECURE)

Circulation

Volumn 103, Issue 7, 2001, Pages 919-925

  Lonn, Eva M ^a,c,e   Yusuf, Salim ^a,c   Dzavik, Vladimir ^b,c   Doris, C Ian ^a,c   Yi, Qilong ^a,c   Smith, Sandra ^a,c   Moore Cox, Anne ^a,c   Bosch, Jackie ^a,c   Riley, Ward A ^d   Teo, Koon K ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c Canadian Cardiovascular Collaboration   (Canada)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Angiotensin; Atherosclerosis; Carotid arteries; Ultrasonics

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO; RAMIPRIL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035916235     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.7.919     Document Type: Article

References (26)

1. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection
2. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
3. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients
4. Effects of long-term vitamin E supplementation on cardiovascular events in 9541 high-risk persons
5. Study design and baseline characteristics of the Study to Evaluate carotid Ultrasound changes in patients treated with Ramipril and vitamin E (SECURE)
6. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis: The Asymptomatic Carotid Artery Plaque Study
7. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
8. A multiple comparisons procedure for comparing several treatments with a control
9. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults
10. Association of coronary artery disease with segment-specific intimal-medial thickening of the extracranial carotid artery
11. Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thickness
12. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
13. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit
14. Effects of captopril on atherosclerosis in cynomolgus monkeys
15. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: No answer yet: Quinapril Ischemic Event Trial
16. Long term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)
17. Randomized, placebo-controlled trial of the angiotensin converting enzyme inhibitor, ramipril, in patients with coronary or occlusive arterial disease
18. Human plasma and tissue α-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E
19. Dose-response comparison of RRR-α-tocopherol and all-racemic α-tocopherol on LDL oxidation
20. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis
21. Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E
22. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary atherosclerosis
23. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
24. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
25. Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia
26. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized study of the effects of vitamins E and C on 3-year progression of carotid atherosclerosis